Advances in genome engineering are attendant on the development of novel enzyme variants with programed substrate specificities and improved activity. We have devised a novel selection method, wherein the activity of a recombinase deletes the gene encoding an inhibitor of an enzyme conferring a selectable phenotype. By using β-lactamase and the β-lactamase inhibitor protein, the selection couples recombinase activity to Escherichia coli survival in the presence of ampicillin. Using this method, we generated λ integrase variants displaying improved in vitro recombination of a non-cognate substrate present in the human genome. One generalist integrase variant displaying enhanced catalytic activity was further used in a facile, single-step transformation method to introduce transgenes up to 8.5 kb into the unique endogenous attB site of common laboratory E.coli strains.
Introduction
Site-specific recombinases (SSRs) have evolved to facilitate the integration of phage genomes into specific chromosomal 'attachment' sites of host organisms (Groth and Calos, 2004) . In contrast to other gene editing enzyme systems such as CRISPR-Cas/9, TALENS and zinc finger nucleases, catalytic recombination mediated by SSRs does not typically invoke the potentially error-prone host DNA repair apparatus, thus significantly minimizing off-target, potentially deleterious modification(s) of host DNA (Miller et al., 2007; Gabriel et al., 2011; Cheng and Alper, 2014; Fine et al., 2014; Kuscu et al., 2014; Lin et al., 2014; Nafissi and Slavcev, 2014; Veres et al., 2014) . However, host repair machinery can become involved when SSR reactions are abrogated or occur at sub-optimal pseudo recombination sites (Chalberg et al., 2006) . The intrinsic high fidelity of endogenous SSRs toward DNA sequences that are not present in the human genome limits their use to targeting of engineered cell lines comprising a high-affinity attachment site pre-integrated either randomly or through homologous recombination (Irion et al., 2007) . Hence, significant efforts have been made to engineer SSRs with programed specificities for downstream applications such as gene therapy where off-target effects cannot be tolerated.
Bacterial selection systems have been described wherein identification of recombinases with desired properties is coupled to the conditional activation of a reporter gene (lacZα) Yagil et al., 1995; Buchholz et al., 1998; Cheng et al., 2000) . The related in vivo substrate-linked protein evolution (SLiPe) methodology (Buchholz and Stewart, 2001 ) has yielded numerous SSR variants with altered properties. SLiPe entails incorporating target DNA sequences into a recombinase-expressing plasmid, such that clonal modification within Escherichia coli leads to a discernable phenotype. The deletion of a restriction site by recombination was initially used to facilitate identification of active enzyme genes by digestion of the selected plasmid pool and PCR amplification (Buchholz and Stewart, 2001) . Progressive iterations have enabled direct colorimetric and fluorescent readouts through linkage of SSR activity to lacZα function or fluorescent protein expression (Santoro and Schultz, 2002; Bolusani et al., 2006) . The latter enables rapid screening by fluorescently activated cell sorting. Both colorimeteric and fluorescence readouts have also been combined in a single selection (Voziyanov et al., 2002) .
SSR activity has also been coupled to functional reassembly of a split β-lactamase gene (Gersbach et al., 2010) . This approach links enzyme fitness with E.coli survival under tunable selection pressure (concentration of antibiotic), allowing for identification of enzymes with significantly enhanced activities. We have recently described a biosensor platform comprising β-lactamase fused to β-lactamase inhibitory protein (BLIP) (Nirantar et al., 2013 (Nirantar et al., , 2014 . The fusion protein is designed such that analyte binding leads to derepression of the β-lactamase and signal readout upon turnover of substrate. As these fusion sensors also coupled analyte detection to antibiotic resistance in vivo, we decided to extrapolate the derepression principle toward the selection of novel λ integrase (INT) enzymes in E.coli. INT principally mediates bi-directional transfer of the bacteriophage λ genome into a 21 bp target site in bacteria (attB), via specific recombination with a 241 bp attachment site (attP) present in its genome (Nash, 1983; Landy, 1989) . Integration and excision catalyzed by INT is dependent on the bacterial DNA-bending factors IHF, FIS and Xis that bind to attP. An engineered co-factor independent integrase variant, Int-h/218, has enabled genomic editing in mammalian and plant cells (Lorbach et al., 2000; Suttie et al., 2008) . Int-h/218 displays similar activity to INT when used for in vivo recombination in E.coli .
The developed selection platform yielded INT variants with improved activity toward attH, a non-cognate substrate present in exon 5 of the monocarboxylate transporter gene 5 in the human genome ( Fig. 1) , which is poorly recombined by INT despite sharing 89% sequence identity with attB. One generalist variant also displayed enhanced recombination on the endogenous attB/attP substrates, and was employed in a facile, robust method to stably integrate heterologous DNA up to 8.5 kb in length into the endogenous attB site of common laboratory E.coli strains.
Materials and methods

Materials
Oligonucleotides were purchased from First Base (Singapore); restriction enzymes, T4 polynucleotide kinase and T4 DNA ligase were from NEB; Pfu DNA polymerase (Stratagene) and Taq DNA polymerase (Bioline) were used for DNA amplification. Nucleic acid purification kits were from Qiagen and chemicals from Sigma. Electrocompetent bacterial TG1 cells were obtained from Lucigen.
Primers and plasmids
Primer sequences and list of plasmids used in this study are provided in Supplementary Tables S1 and S2 .
Vector construction for selection
The pINTS vector was constructed by first introducing the attB sequence into pSN34 (sensor 11 in Nirantar et al., 2013) by inverse PCR using primers attB-invR and attB-invF. The PCR product was phosphorylated using T4 polynucleotide kinase and intramolecular ligation carried using T4 DNA ligase to give the plasmid pSN34-attB. The attP sequence (241 bp comprising core site and ancillary co-factor binding sites) was amplified from the vector pλIR using primers attPINF-F and attPINF-R and introduced into PCRlinearized pET22 vector (using primers petF5 and petR5) by the infusion method (Clontech) to generate pET22-attP. The attP sequence was next amplified from pET22-attP using primers attPINF-2A and attPINF-2B and cloned into PCR-linearized pSN34-attB (using primers PINTVR1 and PINTVF1) by the Infusion method.
Next, the NdeI site at the beginning of the TEM1 ORF was removed by Quickchange mutagenesis (Stratagene) using primers Ndedel1 and Ndedel2. An NdeI site was then introduced at the beginning of the pelB leader sequence preceding the DO1ScFv cassette reading frame by Quickchange mutagenesis using primers NdeINTRO-1 and NdeINTRO-2. An EcoRI site was introduced at the end of the DO1ScFv ORF using primers EcoINTRO-1 and EcoINTRO-2. An extraneous EcoRI site present between the DO1ScFV and TEM1-BLIP expression cassettes was removed by Quickchange mutagenesis using PSNecodel-1 and PSNecodel-2. These modifications facilitated cloning of integrase genes into NdeI/EcoRI cut selection vector. The pINTS-H vector was the same as pINTS except that the attB site was mutated to attH using the primer pair attB-HA and attB-HB, and the attP site was mutated to attPH by Quickchange mutagenesis using the primer pair attP-PHQC3 and attP-PHQC4. The pINTS-H1 selection plasmid (with attHOC1 competitor, Supplementary Fig. S3 ) was generated by amplification of the pINTS-H plasmid using primers attHOC1-PSN-for and PSN-rev. The PCR product was phosphorylated using T4 polynucleotide kinase, and intramolecular ligation carried out using T4 DNA ligase.
Vector construction for secondary recombination assay pλIR (comprising attB × attP) was mutated by Quickchange mutagenesis (Stratagene) using primer pairs attB-H-QC1 and attB-H-QC2 followed by attP-PHQC3 and attP-PHQC4 to create pλIR-attH × attPH. Fig. 1 Sequence alignment of the core bacterial attB site with the human attH sequence. The 7 bp sequence highlighted in gray is the core overlap sequence. In order to allow for efficient recombination to occur, these must be identical in the respective attP and attPH partner sequences shown below. The attHOC1 sequence used as competitor substrate differs from attH by a single base pair (italicized) in the right core-binding sequence. Underlined bases indicate differences between attB and attH/attHOC1. Note, only the 21 bp core sequence of attP and attPH is shown.
This construct was then amplified using primers AttHOC-F and AttHOC-R and the PCR product intramolecularly ligated to generate pλIR-attHOC1 × attPH. The integrase single point mutants I43F and E319G were mutated via Quikchange mutagenesis from pET-Int (Tay et al., 2010) using primer pairs int_I43F_for and int_I43F_rev, and INT-E319G-QC1 and INT-E319G-QC2, respectively.
Selection of integrase variants
The INT gene was randomly mutated via error-prone PCR (Vartanian et al., 1996; Zaccolo and Gherardi, 1999 ) from pET-Int using primers petF2 and petR and then re-amplified using primers tem-INTinfndeF and tem-INFinf-ecoR. The INT library was then ligated into pINTS-H selection vector comprising attH and attPH sites after NdeI/EcoRI restriction. The library was transformed into TG1 cells by electroporation and plated out on nonselective kanamycin plates. Plasmid DNA was isolated from the transformants, and the library plasmid pool was then transformed into TG1 cells and plated on selection plates containing increasing amounts of ampicillin (100-400 µg/ ml). Plasmid DNA was isolated from colonies growing under the most stringent selection pressure (400 µg/ml ampicillin) and INT variant genes encoded by them simultaneously isolated and further diversified using the Staggered Extension Protocol PCR amplification method (Zhao et al., 1998) using primers tem-INTinf-ndeF and temINFinf-ecoR. These were subsequently ligated into selection vector for next round of selection under more stringent conditions (100-600 µg/ml ampicillin). INT-C2 was derived from selection with 600 µg/ml ampicillin. The I43F mutation was introduced into INT-C2 via site-directed mutagenesis with primers int_I43F_for and int_I43F_rev. The resultant double mutant (I43F D336V; C2.1) was used as starting point for further error-prone PCR and selection, this time using the pINTS-H1 selection vector. Selection was carried out as before in the presence of further increasing concentrations of ampicillin (600-900 µg/ml). C3 was derived from selection plates with 900 µg/ml ampicillin.
Secondary recombination assay and quantitative PCR
The variant integrase genes present in colonies were amplified by colony PCR with primers IntRBS-F and INTstop-R, followed by amplification with primers Universal and INTstop-R. These primers append the T7 RNA promoter and RBS sites required for in vitro transcription and translation. Screening of clones was carried out using in vitro coupled transcription-translation followed by real-time PCR as previously described (Tay et al., 2010) with the following modifications: 20 ng of each integrase amplicon was expressed using PURExpress ® In Vitro Protein Synthesis Kit (NEB) in a total volume of 9 µl at 30°C for 1 h. Intramolecular recombination was then carried out by adding 10 ng plasmid substrate ( pλIR containing either attB × attP sites, attPH × attH sites or attPH × attHOC1 sites) to a total volume of 10 µl. The mixture was allowed to incubate for 2 h at 30°C. The reaction was subsequently diluted 1/10 before taking 1 µl for real-time PCR quantification of recombination efficiency. Real-time PCR quantification was carried out with 250 nM each of primers pLIR-F1 and pLIR-R1 in a final volume of 20 µl with SsoAdvanced™ Universal SYBR ® Green Supermix.
Real-time PCR to determine different ratio of full-length integrase to Y342Adel (in E.coli colonies growing on kanamycin plates) was carried out on the plasmid pool with 250 nM each of primers INT-F2 and INT-R2 (to detect for full-length integrase only) and another set of primers INT-A and INT-B (to detect for both full-length integrase and Y342Adel) using 1 ng of the plasmid sample in a final volume of 20 µl with SsoAdvanced™ Universal SYBR ® Green Supermix (Bio-Rad Laboratories) and quantified via CFX96 Real-Time System (Bio-Rad Laboratories).
Protein expression and purification
Plasmids expressing INT and INT-C3 with C-terminal histidine tags were transformed into E.coli BL21(DE3)pLysS (Invitrogen) competent cells. The bacterial cells were grown in LB medium at 37°C and induced at OD 600nm of ∼0.6 with 0.5 mM IPTG at 30°C for 6 h. The cells were then harvested by centrifugation, re-suspended in 50 mM Tris pH 8.0, 1 M NaCl, 20 mM imidazole and lysed by sonication. The cell lysate was clarified by high-speed centrifugation and the supernatant was then applied to a 1 ml HisTrap™ FF column (GE Healthcare) pre-equilibrated in binding buffer (50 mM Tris-HCl pH 8.0, 1 M NaCl, 20 mM imidazole, 0.5 mM EDTA and 2 mM DTT).
The column was washed with binding buffer and the integrase proteins were eluted off the column via gradient elution over 30 column volumes with 50 mM Tris-HCl pH 8.0, 1 M NaCl, 500 mM imidazole, 0.5 mM EDTA and 2 mM DTT. Collected fractions were analyzed by SDS-PAGE gel and the appropriate fractions were dialyzed and concentrated in 50 mM Tris pH 8.0, 1 M NaCl, 0.5 mM EDTA and 2 mM DTT using Amicon-Ultra (10 kDa MWCO) prior to storage at −80°C.
In vitro recombination assay using purified INT Intramolecular recombination was carried out with 5 µg of purified recombinant integrase protein incubated with 10 ng plasmid substrate ( pλIR containing either attB × attP sites, attPH × attH sites or attPH × attHOC1 sites). Reactions (25 µl) were carried out for 1.5 h at 30°C in recombination buffer (100 mM Tris pH 7.5, 500 mM NaCl, 25 mM DTT, 10 mM EDTA, 5 mg/ml bovine serum albumin). The reaction was diluted 1/10 before taking 2 µl for real-time PCR quantification of recombination efficiency. Real-time PCR quantification was carried out with 250 nM each of primers pLIR-F1 and pLIR-R1 in a final volume of 20 µl with SsoAdvanced™ Universal SYBR ® Green Supermix.
Cell culture and ex vivo recombination assay
Episomal intramolecular recombination assays were carried in the HT1080 cell line (Rasheed et al., 1974) . 3 × 10 5 cells were seeded in Dulbecco's modified Eagle's medium [DMEM (Life technologies) supplemented with 10% FBS, 1% L-glutamine and 100 U/ml of Penicillin and Streptomycin each] per well of 6-well plate a day before transfection to obtain 70-90% confluence at the time of transfection. Transfections were carried out using Lipofectamine 2000 reagent. For each transfection per well, plasmid DNA-lipid complexes were prepared by mixing 1.5 µg of pλIR and 1.5 µg of the λ integrase expression plasmid diluted in 100 µl of Opti-MEM medium with 6 µl of Lipofectamine 2000 reagent diluted in 100 µl of Opti-MEM medium and incubating for 20 min at room temperature. The transfection mix was added dropwise onto the cells (under DMEM minus antibiotics) and transfection was allowed to proceed for 4-6 h. Complexes were then removed by replacing with fresh DMEM medium. Forty-eight to seventy-two hours post-transfection, the cells were trypsinised and harvested with DMEM into eppendorf tubes, pelleted by centrifugation (at 1000× rcf for 5 min) and resuspended in 1 ml fresh DMEM. Green fluorescent protein (GFP) positive cells were quantified by FACS on a BD FACSCalibur™ machine (Becton-Dickinson).
Southern hybridization
Escherichia coli genomic DNA of the untargeted and targeted clones was purified using DNeasy Blood & Tissue Kit (Qiagen, GmbH). A total of 500 ng of genomic DNA from each clone was subjected to restriction digestion using 20 U of PstI restriction enzyme overnight at 37°C in a volume of 30 µl. Targeting vectors linearized with single cutter PstI enzyme and diluted to 10 8 and 5 × 10 8 copies/µl were used as positive control for the blot. Digested genomic DNA samples were resolved by overnight electrophoresis on a 1% agarose (Bio-Rad) gel in 1 × TAE, with 1 kb DNA ladder (New England Biolabs) and 1 µl of positive control samples. Southern blotting employing the internal probe targeting TEM1 gene (generated using primers B-lac-fwd and B-lac-rev) and external probe targeting flanking E.coli genomic sequence (generated using primers Ex-fwd and Ex-rev) was performed using the DIG-High Prime DNA Labeling and Detection Starter Kit II (Roche) as per the suppliers protocol. The probe-target hybrids on the blots were detected by chemiluminescent assay followed by exposure to an X-ray film (Kodak MXG film, Kodak) and developed on a Kodak X-OMAT 2000 Processor.
Rapid E.coli chromosomal integration
The C3INT-HIS-PET22b(+) plasmid was amplified with petF2 and petR and the PCR product subsequently intramolecularly ligated to produce a C3INT-HIS minicircle. The plasmid attP-PET22b(+) was amplified with attP-F and attPSOE-R, and pET22b(+) was amplified with TEM1prom-F and TEM1prom-R. This produced PCR products containing attP and the ampicillin-resistant gene expression cassette, respectively. Splicing by overlap extension PCR was carried out with these two PCR products using attP-F and TEM1prom-R. The resultant PCR product was subsequently intramolecularly ligated to produce attP-TEM1 minicircles. A total of 100 ng of C3INT-HIS minicircle and 100 ng attP-TEM1 minicircle were combined and electroporated into 25 µl electrocompetent TG1 cells. The cells were allowed to recover for 1 h at 37°C before being plated on varying concentrations of ampicillin-LB agar plates (0.01, 0.02, 0.05, 0.07 and 0.1 mg/ml). Incubation was carried out at 37°C for 12-14 h to allow for expression of C3 integrase and chromosomal integration of the ampicillin-resistance cassette. Colony PCR was carried out with EcoliAttB-F and EcoliAttB-R, TEM1prom-F and EcoliAttB-F or TEM1prom-F and EcoliAttB-R to verify the presence of chromosomal integration. The PCR products were also sequenced with the same primers to confirm the results.
Results
Selection platform and validation
The selection principle is outlined in Fig. 2 We first validated the system by ligating genes encoding INT or an inactive deletion mutant (INT-Δ) into the selection plasmid pINTS (comprising attB and attP sites), transforming E.coli and assaying colony formation after plating on ampicillin selection plates or nonselecting kanamycin plates. Note that the parental INT used throughout comprises the E174K and E218K mutations rendering it co-factor independent . Escherichia coli transformed with selection plasmids expressing active INT showed a clear growth advantage in the presence of ampicillin (Fig. 3) . At the lower ampicillin concentration (50 µg/ml), colonies expressing the inactive INT-Δ were also observed, most likely arising from incomplete inhibition of the β-lactamase by the BLIP in the fusion protein. At the higher concentration of ampicillin (100 µg/ml), this 'noise' was effectively eliminated. Plating on nonselective kanamycin plates did not lead to any significant differences in the number of colonies observed for the INT and INT-Δ transformations. We next carried out model selections to determine the efficiency of the system. Genes encoding INT or INT-Δ were combined at varying ratios, and cloned into selection vector comprising attB and attP sites prior to transformation and spreading on plates containing ampicillin or kanamycin. Colony PCR on growing colonies was then carried out to check for INT status and deletion of the BLIP gene. The results indicate that within a single round, functional INT genes could be selected from a 100-fold excess of inactive INT genes (5/15 colonies for the 1:100 ratio contained active INT gene, corresponding to a 33-fold enrichment) ( Supplementary Fig. S1A ). Commensurate deletion of the BLIP gene was observed in selected colonies expressing functional INT. In the absence of selective pressure ( plating on kanamycin plates), we noted that INT status did not correspond to the input ratio of active to inactive INT genes ( Supplementary Fig. S1B ). Even after screening 124 colonies from the 1:10 (active:inactive) ratio transformation, we did not observe any colonies containing the functional INT gene. Real-time PCR screening of the plasmid pool from all the colonies growing on the plate indicated the ratio to be ∼1:182. The discrepancy most likely results from sporadic INT-mediated integration of the entire selection plasmid into the endogenous attB site of the E.coli host, resulting in cell death (due to integration of the plasmid ori sequence into the E.coli genome). In the context of this negative selection pressure, the true enrichment per round is in the order of 600-fold. Fig. 3 Survival of E.coli on ampicillin selection plates corresponds to the expression of active INT. Genes encoding functional INT or an inactive deletion mutant (INT-Δ) were ligated into pINTS (to assay attB × attP recombination), transformed into E.coli cells and plated on either ampicillin selection plates or kanamycin plates (10% of transformation plated on latter). n = 4 ± SD. Fig. 4 (A) Improved recombination of both endogenous and alternate att sites by selected INT mutants. Enzymes were expressed using an in vitro transcription/ translation system and recombination of target sites in a plasmid substrate determined by real-time PCR. Activity is denoted relative to that of parental INT on the endogenous attB × attP substrate pair (set to 1) (n = 3 ± SD). (B) Improved recombination of both endogenous and alternate att sites by purified INT-C3. n = 3 ± SD. INT-C3 and indicated point mutants were assayed for recombination of attB × attP and attH × attPH. Enzymes were expressed using an in vitro transcription/translation system and recombination of target sites in a plasmid substrate determined by real-time PCR. Activity is denoted relative to that of parental INT on the endogenous attB × attP substrate pair (set to 1). n = 3 ± SD.
Selection of novel λ integrase variants
The INT gene was subsequently randomly mutated and selection carried out for improved recombination of the attH and attPH sites. After one round of selection, secondary analysis of clones growing on the highest ampicillin concentrations yielded two variants that respectively showed ∼7-and 2-fold improved activity over parental INT for attH/attPH recombination ( Supplementary Fig. S2 ). Sequence analysis revealed the mutations D336V (INT-C2) and I43F, E264G (INT-C1).
The I43F mutation previously arose in an independent in vitro-based selection for improved recombination of the same attH/attPH substrate pair (Tay et al., 2010) . Combination of this mutation with the D336V mutation present in INT-C2 (to yield INT-C2.1) resulted in a further improvement in activity on the attH/PH substrate pair (∼10-fold compared with parental INT) (Fig. 4A) . INT-C2.1 was next used as the starting template for a further round of errorprone PCR and selection. To increase stringency, a competitor substrate (attHOC1), differing from attH by only the first base pair in the right core-binding sequence (Fig. 1) , was introduced into the selection vector. In vitro assays showed that attPH/attHOC1 recombination was as efficient as attB/P recombination by INT (Fig. 4A) . The attHOC1 sequence was placed upstream of the TEM1-BLIP fusion protein ORF, such that 'off-target' recombination between attPH and attHOC1 would result in deletion of the entire TEM1-BLIP gene on the plasmid and non-growth on selective media (Supplementary Fig. S3 ).
One further round of selection on further increasing concentrations of ampicillin yielded a single clone (INT-C3) that showed a 2-fold improvement over INT-C2.1 (Supplementary Fig. S4 ). This variant contained the E319G mutation in addition to the I43F and D336V mutations. The selectants were next assayed for recombination of differing substrate pairs (attB/P, attH/PH and attHOC1/PH) using either purified ( Supplementary Fig. S5 ) or in vitro expressed enzymes. The C3 variant was able to recombine attH/PH ∼4-fold more efficiently than INT recombined the endogenous attB/P substrates using both in vitro expressed (Fig. 4A) and purified, recombinant proteins (Fig. 4B) .
The increased activity on the attH/PH substrates was commensurate with increased activity on the attB/P and attHOC1/PH substrates. However, the fold increase in activity of C3 over INT for attH/PH compared with the other substrate pairs was consistently ∼2-fold higher, indicating a limited skewing of specificity toward attH/PH recombination. The three mutations present in INT-C3 were next looked at in isolation to gauge their relative contributions (Fig. 5) . The I43F, D336V and E319G point mutants, respectively, showed 1.9-, 11.8-and 28.6-fold increased activity over INT for attH/PH recombination. INT-C3 was 48.9-fold more active in the same assay, Protocol for rapid transgene integration into the endogenous attB site of E.coli. Minicircles comprising the INT-C3 expression cassette (left) and minicircles comprising the heterologous gene of interest, the TEM1 expression cassette and attP (right) are combined and transformed into E.coli. Integrase activity leads to integration of the complete minicircle comprising TEM1 expression cassette and transgene of interest into the E.coli attB site. Colonies growing on selective ampicillin media are assayed for correct integration by PCR using primers that bind E.coli genomic DNA sequences flanking the integration site (red arrows). DNA sequences originating from parental vectors during synthesis of minicircles are depicted in orange.
indicating a broadly additive contribution of the three mutations toward its recombination phenotype. The point mutations also resulted in increased activity on attB/P substrates. However, as with INT-C3, the increased activity of the point mutants over INT on attH/PH was 2-to 3.5-fold higher than that on attB/P.
Recombination of episomal substrates
The INT variants were next assayed in human HT1080 cells using an episomal plasmid substrate that links correct recombination to GFP expression , allowing for INT activity to be determined by FACS analysis. Compared with INT, C2.1 and C3 respectively showed a 1.5-and 1.9-fold increase in recombination of attH/PH (Fig. 6) . As with the in vitro assays, increased recombination of attB/P was also observed, albeit with comparatively lower magnitudes (1.2-fold for both C2.1 and C3).
Targeted recombination in E.coli
Given the improved activity seen for recombination of attB/P by INT-C3, we next assayed it for stable integration of DNA into the endogenous attB site of E.coli. DNA minicircles were generated by amplification of the INT or C3 gene expression cassettes followed by intramolecular ligation (Fig. 7) . Additionally, 1.6 kb minicircles comprising the ampicillin-resistance gene expression cassette and an attP site were also generated. The minicircles were co-transformed into E.coli and plated onto ampicillin-containing selection plates. Within the cell, INT activity should recombine the entire attP-containing minicircle into the endogenous attB site. In the absence of an ori, the minicircle expressing the INT will be eliminated thus ensuring irreversible integration. The results indicate targeted integration of the entire minicircle comprising the ampicillin-resistance cassette into the endogenous attB site mediated by C3, with an ∼37-fold increased efficiency over INT (Fig. 8A and B) . Both Southern blot ( Fig. 9A and B) and DNA sequence analysis ( Supplementary Fig. S6 ) further confirmed single copy, site-specific integration in five of six E.coli integrants. To further assess the robustness of INT-C3, an ∼9 kb minicircle comprising a synthetic operon and antibiotic resistance cassette was constructed and co-transformed into E.coli. As before, successful targeting of the endogenous attB site was achieved with high efficiency and confirmed by DNA sequencing (Fig. 8C and Supplementary Fig. S7 ). In contrast, the use of the parental INT did not give rise to any integrants.
Discussion
Autoinhibition coupled to derepression is a naturally occurring paradigm, having been observed in the DNA methyltransferase DNMT1 and cyclin-dependent kinases (Nolen et al., 2004; Song et al., 2011) . We have previously exploited this principle in the construction of synthetic fusions comprising β-lactamase and its inhibitor BLIP for use as biosensors (Nirantar et al., 2013 (Nirantar et al., , 2014 . In this application, ligand binding and/or protease activity on the customized fusion protein linker region causes derepression of β-lactamase by dislocation of BLIP, leading to enzyme activity and signal readout. We reasoned that derepression mediated by genetic deletion of the BLIP gene component of the fusion protein would link recombinase activity to β-lactamase function. The results indicate this to be the case, and we were able to select an INT variant with significantly improved recombination properties on the non-cognate substrate pair attH/PH. While this variant performed significantly better than parental INT both in vitro and in a mammalian cell-based episomal assay, it was unable to integrate a plasmid comprising an attPH site into the endogenous attH site in a mammalian cell line. The parental INT used in this study is efficient at targeting a single copy attB site pre-integrated into the genome . In the cell-based episomal assay, the activity of INT-C3 on attH/PH substrates was comparable with that of INT on attB/P (24.18 versus 30.67%, respectively). However, the higher attH substrate concentrations used for this assay ( provided in transfected Escherichia coli was co-transformed with a minicircle comprising attP sequence and TEM1 expression cassette along with a minicircle comprising an INT expression cassette. Cells were plated on growth media comprising either 70 or 100 µg/ml ampicillin. 'Total' indicates number of colonies counted after overnight incubation. 'Specific' indicates the number of colonies showing recombination into attB as determined by colony PCR. n = 2 ± SD. (B) Colony PCR using primers flanking attB integration site (Fig. 7) indicating the presence of correctly integrated ∼1.6 kb transgene (TEM1 cassette only, arrowed) into the endogenous attB site of E.coli mediated by INT (1/2 colonies) or INT-C3 (11/11 colonies). NTC corresponds to no template PCR control. (C) Colony PCR (nine colonies) indicating the presence of correctly integrated ∼8.5 kb DNA fragment comprising TEM1 cassette (∼1.6 kb), parental vector (∼3.7 kb) and synthetic operon (∼3.2 kb), into the endogenous attB site of E.coli mediated by INT-C3 (arrowed).
plasmid) could mask a deficiency in the activity of INT-C3 that would manifest at the low endogenous levels (two copies per cell) of attH. A further possibility is that this endogenous attH sequence resides in a chromosomal region that is inherently refractory to targeting by virtue of higher order structure and/or transcriptional inactivity.
Adaptation by recombinases to novel substrate sequences is commonly associated with relaxed substrate specificities Yagil et al., 1995; Buchholz and Stewart, 2001; Bolusani et al., 2006; Tay et al., 2010) . This driving force has played a role in the evolution of INT-C3, despite the introduction of a competitor substrate (attHOC1) between rounds 1 and 2 of the selection. INT variants that recombined attHOC1 with attPH would be expected to disappear from the gene pool due to deletion of the β-lactamase gene along with antibiotic selection pressure. However, the presence of multiple copies of the selection plasmid within each E.coli cell most likely attenuated attHOC1 competition. Even if the majority of plasmids were incorrectly recombined, a single correct attH/PH recombination event would ensure persistence of the selection plasmid and the INT variant encoded within. In this respect, a more judicious choice of competitor substrates and relative arrangement within the selection plasmid could be used in future studies. An additional consideration is selection from focused libraries (randomization of DNA-contacting residues only), which has yielded recombinase variants with novel substrate preferences that do not display general relaxed substrate specificities (Gaj et al., 2011) . We selected from a library of INT variants randomized across all three constituent domains, and the majority of mutations found in the most active selectants do not map to the immediate vicinity of the protein-DNA interface (see below). A further approach entails combination of evolutionary and rational, structure-guided approaches to modulate recombinase specificity (Abi-Ghanem et al., 2013) .
The INT structure comprises three discrete domains whose coordinated actions both in cis and in trans mediate assembly and function of a higher order tetrameric complex known as an intasome (Biswas et al., 2005) . The N-terminal DNA binding domain (residues 1-63) recognizes 'arm-type' DNA sequences adjacent to the attP core site. Binding results in allosteric licensing of core-binding (CB) domain (residues 75-175) and C-terminal catalytic domain (residues 176-356) function (Franz and Landy, 1995; Biswas et al., 2005) . The CB domain primarily engages the 7 bp attP × attB core DNA sequence motifs and is coupled to the catalytic domain responsible for DNA cleavage and rejoining. The I43F mutation that arose in round 1 of selection has previously been identified to enhance recombination of attH by INT (Tay et al., 2010) . As I43 does not interact directly with arm-site DNA, it was speculated that this N-terminal domain mutation impacted on the allosteric rearrangements that drive resolution of the intermediate Holliday junction toward recombined products. In isolation, the I43F mutation did not result in a significant increase in recombination of the plasmid attH/PH substrate. However, it did potentiate the activity of the D336V mutation present in the catalytic domain. Additionally, it most likely contributed toward improving function of the E264G mutation in selectant INT-C1 (I43F/E264G) ( Supplementary Fig. S2 ).
The catalytic domain residue D336 resides in a highly flexible loop (residues 335-341) adjacent to the Y342 nucleophile that mediates DNA cleavage (Fig. 10) . It is not proximal to the first base pair in the right arm of the core-binding sequence that is mutated in attH and renders it a poor substrate for INT (Figs 1 and 4) . There is an absolute requirement for flexibility of the region comprising the tyrosine nucleophile in tyrosine recombinases (Chen et al., 2000; Conway et al., 2003; Subramaniam et al., 2003) , and the D336V mutation could impact on this favorably. The E319G mutation (also in the catalytic domain) in INT-C3 has been previously described to relax substrate specificity of INT . In addition to being proximal to the Y342 nucleophile, E319 is also proximal to the charged C-terminus of INT (residues 346-356) (Fig. 10) . This region plays a clear role in regulation of site-specific recombination, with deletion or mutation impacting on DNA binding, cleavage and ligation activities (Han et al., 1994; Kazmierczak et al., 2002) .
Lambda integrase has been used to introduce transgenes into the endogenous attB site of E.coli. This has been achieved by in vitro Cre-mediated generation of minicircles containing attP (and lacking an ori) and co-transformation with an INT-expressing plasmid containing a thermosensitive replicon (Hasan et al., 1994) . A related method dispenses with the minicircle formation by using a further conditional replicon on an attP-containing plasmid (Haldimann and Wanner, 2001 ). This process has been further streamlined by incorporating the INT expression cassette into the targeting plasmid comprising attP and heterologous gene of interest (St-Pierre et al., 2013) . Using INT-C3, we were able to efficiently target the same site with large (∼8.5 kb) inserts using a modified protocol to generate ori-free minicircles along with a single-step transformation/growth procedure that obviated both the use of conditional replicons (and obligate curing steps), and dedicated E.coli strains to propagate plasmids. Given the inherent propensity of the attB site to stably accommodate the large bacteriophage lambda genome (∼48.5 kb), it is probable that even larger heterologous DNA fragments can be inserted using INT-C3. We foresee this as a significant enabling application given the large interest in using engineered bacteria as cell-factories to generate specialty chemicals and proteins.
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Supplementary data are available at PEDS online.
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This work was supported by ETPL (Agency for Science Technology and Research, Singapore). Fig. 10 Proximity of the D336 and E319 residues mutated in INT-C3 to the Y342 nucleophile and catalytic domain C-terminal region. D336 resides on a highly flexible region comprising the Y342 nucleophile (yellow). E319 is proximal to both the Y342 nucleophile and the C-terminal region (cyan) implicated in control of INT catalytic activity. Two constituent catalytic domains (green and magenta) are depicted, with CB domains shown in gray. Adapted from PDB structure 1Z19 (Biswas et al., 2005) .
